Connection
John Rumsfeld to Angiotensin Receptor Antagonists
This is a "connection" page, showing publications John Rumsfeld has written about Angiotensin Receptor Antagonists.
|
|
Connection Strength |
|
 |
|
 |
|
0.155 |
|
|
|
-
Maddox TM, Ho PM, Roe M, Dai D, Tsai TT, Rumsfeld JS. Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry. Circ Cardiovasc Qual Outcomes. 2010 Nov; 3(6):632-41.
Score: 0.088
-
Ho PM, Magid DJ, Masoudi FA, McClure DL, Rumsfeld JS. Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease. BMC Cardiovasc Disord. 2006 Dec 15; 6:48.
Score: 0.067